Technical Analysis for TSSNF - Tissue Regenix Group Plc

Grade Last Price % Change Price Change
grade D 0.07 0.00% 0.0000
TSSNF closed unchanged on Friday, August 2, 2019, on 42 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical TSSNF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -22.22%
Gapped Up Strength -22.22%
New 52 Week Closing Low Bearish -16.67%

Older signals for TSSNF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and Cardiac divisions. The company's decellularisation (dCELL) technology removes DNA and other cellular material from animal and human tissue leaving intact an inert acellular matrix upon which the patient's cells can repopulate. Its dCELL technology has applications in various clinical needs, such as wound care, and heart valve replacement. It offers DermaPure used for the treatment and management of complex and chronic wounds; and SurgiPure XD for the repair of hernias and/or body wall defects, which require the use of reinforcing or buttressing material to obtain the desired surgical outcome. The company is also developing OrthoPure XM, which makes the implant biocompatible and provides a biomechanically appropriate scaffold for cellular repopulation and eventual regeneration in the partial meniscectomy; OrthoPure XT and OrthoPure HT used for the anterior cruciate ligament injuries; and CardioPure for the replacement of human aortic and pulmonary valves. Tissue Regenix Group plc was incorporated in 2006 and is based in Leeds, the United Kingdom.
Medicine Medical Specialties Surgery Medical Technology Regenerative Medicine Biomaterials Tissue Engineering Prosthetics Biomedical Engineering Chronic Wounds Implant Platform Technologies
Is TSSNF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.145
52 Week Low 0.07
Average Volume 2,390
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0936
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0700
Resistance 3 (R3) 0.0700 0.0700 0.0700
Resistance 2 (R2) 0.0700 0.0700 0.0700 0.0700
Resistance 1 (R1) 0.0700 0.0700 0.0700 0.0700 0.0700
Pivot Point 0.0700 0.0700 0.0700 0.0700 0.0700
Support 1 (S1) 0.0700 0.0700 0.0700 0.0700 0.0700
Support 2 (S2) 0.0700 0.0700 0.0700 0.0700
Support 3 (S3) 0.0700 0.0700 0.0700
Support 4 (S4) 0.0700